The average P/S ratio for TMDX's competitors is 3.12, providing a benchmark for relative valuation. Transmedics Group Inc Corp (TMDX) exhibits a P/S ratio of 6.09, which is 95.07% above the industry average. Given its robust revenue growth of 48.21%, this premium appears sustainable.